German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.
Throughout 2024, it felt as if a new amazing RPG was right around the corner at every moment. The year kicked off with a bang when Like A Dragon: Infinite Wealth launched just before Persona 3 Reload ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
It’s here: The winners and finalists of our annual Best of Dayton 2026 competition have been announced. Updated Jul 15, 2026 The Dayton Dragons baseball team is a first-place winner in two categories ...
A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...
A Merck KGaA, Darmstadt, Germany, researcher at work. Merck KGaA has agreed to acquire Bio-Techne for approximately $11.3 billion, in a deal designed to position the buyer as more of a leader across ...
Since 1971, Travel + Leisure editors have followed one mission: to inform, inspire, and guide travelers to have deeper, more meaningful experiences. T+L's editors have traveled to countries all over ...
Merck offered $73 per share, implying a 24% premium to Wednesday's close Merck expects deal to close by late 2026 or early 2027 Sees about 140 million euros in cost savings by the third year after ...
Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...
Celebrating the best local businesses across Southwestern PA. TribLIVE’s Best of the Best Community Choice Awards recognize and honor the best local businesses across the region. Starting July 20, ...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and ...
Germany’s Merck MRK0.07%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH 0.21%increase; up pointing triangle for $11.3 billion, in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results